Maryland

REGENXBIO to Host RGX-314 Program Analyst and Investor Event with Leading Retina Specialists

ROCKVILLE, Md., Feb. 14, 2019 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq:RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV® Technology…
Continue Reading »
Maryland

Federal Realty Investment Trust Announces Operating Results for the Year and Quarter Ended December 31, 2018

ROCKVILLE, Md., Feb. 13, 2019 /PRNewswire/ -- Federal Realty Investment Trust (NYSE: FRT) today reported operating results for its year and quarter ended December 31, 2018. For the year ended December…
Continue Reading »
Maryland

Statement from FDA Commissioner Scott Gottlieb, M.D. and Deputy Commissioner Frank Yiannas on findings from the agency’s investigation of the November 2018 outbreak of E. coli O157:H7 in California-linked romaine lettuce

SILVER SPRING, Md., Feb. 13, 2019 /PRNewswire/ -- The Food and Drug Administration and the Centers for Disease Control and Prevention acted quickly to protect consumers from an emerging outbreak of…
Continue Reading »
Maryland

Statement from FDA Commissioner Scott Gottlieb, M.D. on new programs to promote the adoption of innovations in drug manufacturing that can improve quality and lower drug costs

SILVER SPRING, Md., Feb. 13, 2019 /PRNewswire/ -- Ensuring the safety of our nation's drug supply is a cornerstone of our consumer protection mission. One of the fundamental elements of overseeing…
Continue Reading »
Maryland

Dr. Alison Potok and Dr. Pablo Garcia join distinguished group of nephrology’s top researchers as American Kidney Fund Clinical Scientist in Nephrology fellows

ROCKVILLE, Md., Feb. 13, 2019 /PRNewswire/ -- The American Kidney Fund is marking the 30th year of its Clinical Scientist in Nephrology Program in 2019 with the announcement of two research…
Continue Reading »